MPI DTPA KIT - CHELATE Drug Patent Profile
✉ Email this page to a colleague
When do Mpi Dtpa Kit - Chelate patents expire, and what generic alternatives are available?
Mpi Dtpa Kit - Chelate is a drug marketed by Ge Healthcare and is included in one NDA.
The generic ingredient in MPI DTPA KIT - CHELATE is technetium tc-99m pentetate kit. There are four drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the technetium tc-99m pentetate kit profile page.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for MPI DTPA KIT - CHELATE?
- What are the global sales for MPI DTPA KIT - CHELATE?
- What is Average Wholesale Price for MPI DTPA KIT - CHELATE?
Summary for MPI DTPA KIT - CHELATE
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Raw Ingredient (Bulk) Api Vendors: | 105 |
| Clinical Trials: | 30 |
| DailyMed Link: | MPI DTPA KIT - CHELATE at DailyMed |
Recent Clinical Trials for MPI DTPA KIT - CHELATE
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| Bayer | Phase 3 |
| Next Science LLC | Phase 4 |
| St. Louis University | Phase 4 |
US Patents and Regulatory Information for MPI DTPA KIT - CHELATE
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Ge Healthcare | MPI DTPA KIT - CHELATE | technetium tc-99m pentetate kit | INJECTABLE;INJECTION | 017255-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
